Upgrade to SI Premium - Free Trial

TD Cowen Reiterates Buy Rating on Novo Nordisk (NVO)

February 3, 2026 9:33 AM
TD Cowen analyst Michael Nedelcovych reiterated a Buy rating and $70.00 price target on Novo Nordisk (NYSE: NVO).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles